切除活检但组织学边缘阳性的中度异型增生痣后续皮肤黑色素瘤风险
这项多中心回顾性队列研究纳入438例患者共467个组织学边缘阳性的中度异型增生痣,随访至少3年。活检部位无黑色素瘤发生,但100例患者(22.8%)在身体其他部位发生皮肤黑色素瘤。黑色素瘤病史和既往活检异型增生痣与后续皮肤黑色素瘤风险显著相关。
要点
- 组织学边缘阳性的中度异型增生痣在平均6.9年随访中无1例在活检部位发生皮肤黑色素瘤。
- 438例患者中100例(22.8%)在身体其他部位发生皮肤黑色素瘤。
- 黑色素瘤病史(OR 11.74)和既往活检异型增生痣(OR 2.55)与后续皮肤黑色素瘤风险显著相关。
核心结论
- 本研究提示,对于组织学边缘阳性的中度异型增生痣,密切观察联合常规皮肤监测是一种合理的管理方式。
- 拥有2个或以上活检异型增生痣(其中1个为中度异型增生痣)似乎与身体其他部位后续皮肤黑色素瘤风险增加相关。
研究设计与样本
- 多中心(美国9个学术皮肤病学站点)回顾性队列研究,纳入1990年1月1日至2014年8月31日连续收集的18岁及以上、组织学边缘阳性的中度异型增生痣且随访数据≥3年的患者。
- 共评估438例患者(193例女性、245例男性;平均[SD]年龄46.7[16.1]岁)的467个组织学边缘阳性的中度异型增生痣。
- 采用χ2检验、Fisher精确检验和方差分析评估后续皮肤黑色素瘤风险的单变量关联,并采用多变量逻辑回归模型。
- 每个站点提交5例随机代表性切片病例进行中心皮肤病理学复核以确认组织学分级。
- 统计分析于2017年10月1日至2018年6月22日进行。
主要发现
- 活检部位无黑色素瘤发生,平均(SD)随访时间6.9(3.4)年。
- 100例患者(22.8%)在身体其他部位发生皮肤黑色素瘤。
- 多变量分析显示,黑色素瘤病史与身体其他部位后续皮肤黑色素瘤风险显著相关(OR 11.74;95%CI 5.71-24.15;P<.001)。
- 既往活检异型增生痣与身体其他部位后续皮肤黑色素瘤风险显著相关(OR 2.55;95%CI 1.23-5.28;P=.01)。
- 中心皮肤病理学复核显示40例中35例(87.5%)一致;40例中3例(7.5%)异型程度升级,其中1例被解读为原位黑色素瘤,该患者随访5年后仍无复发或皮肤黑色素瘤证据。
关键数值与推荐
- 黑色素瘤病史:OR 11.74(95%CI 5.71-24.15;P<.001)。
- 既往活检异型增生痣:OR 2.55(95%CI 1.23-5.28;P=.01)。
- 中心皮肤病理学复核一致率:35/40例(87.5%)。
- 中心皮肤病理学复核异型程度升级:3/40例(7.5%),其中1例为原位黑色素瘤。
临床怎么用
- 作者认为,对于组织学边缘阳性的中度异型增生痣,密切观察联合常规皮肤监测是一种合理的管理方式。
- 作者指出,拥有2个或以上活检异型增生痣(其中1个为中度异型增生痣)似乎与身体其他部位后续皮肤黑色素瘤风险增加相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Little evidence exists to guide the management of moderately dysplastic nevi excisionally biopsied without residual clinical pigmentation but with positive histologic margins (hereafter referred to as moderately dysplastic nevi with positive histologic margins). OBJECTIVE: To determine outcomes and risk for the development of subsequent cutaneous melanoma (CM) from moderately dysplastic nevi with positive histologic margins observed for 3 years or more. DESIGN, SETTING, AND PARTICIPANTS: A multicenter (9 US academic dermatology sites) retrospective cohort study was conducted of patients 18 years or older with moderately dysplastic nevi with positive histologic margins and 3 years or more of follow-up data collected consecutively from January 1, 1990, to August 31, 2014. Records were reviewed for patient demographics, biopsy type, pathologic findings, and development of subsequent CM at the biopsy site or elsewhere on the body. The χ2 test, the Fisher exact test, and analysis of variance were used to assess univariate association for risk of subsequent CMs, in addition to multivariable logistic regression models. To confirm histologic grading, each site submitted 5 random representative slide cases for central dermatopathologic review. Statistical analysis was performed from October 1, 2017, to June 22, 2018. MAIN OUTCOMES AND MEASURES: Development of CM at a biopsy site or elsewhere on the body where there were moderately dysplastic nevi with positive histologic margins. RESULTS: A total of 467 moderately dysplastic nevi with positive histologic margins from 438 patients (193 women and 245 men; mean [SD] age, 46.7 [16.1] years) were evaluated. No cases developed into CM at biopsy sites, with a mean (SD) follow-up time of 6.9 (3.4) years. However, 100 patients (22.8%) developed a CM at a separate site. Results of multivariate analyses revealed that history of CM was significantly associated with the risk of development of subsequent CM at a separate site (odds ratio, 11.74; 95% CI, 5.71-24.15; P < .001), as were prior biopsied dysplastic nevi (odds ratio, 2.55; 95% CI, 1.23-5.28; P = .01). The results of a central dermatopathologic review revealed agreement in 35 of 40 cases (87.5%). Three of 40 cases (7.5%) were upgraded in degree of atypia; of these, 1 was interpreted as melanoma in situ. That patient remains without recurrence or evidence of CM after 5 years of follow-up. CONCLUSIONS AND RELEVANCE: This study suggests that close observation with routine skin surveillance is a reasonable management approach for moderately dysplastic nevi with positive histologic margins. However, having 2 or more biopsied dysplastic nevi (with 1 that is a moderately dysplastic nevus) appears to be associated with increased risk for subsequent CM at a separate site.
引用
- Kim CC, Berry EG, Marchetti MA, et al. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018. PMID: 30304348. doi:10.1001/jamadermatol.2018.3359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。